Breaking news

Flo Health Secures $200M Investment From General Atlantic, Signaling A New Era In Femtech

In a landmark move for the femtech industry, Flo Health has secured a $200 million investment from General Atlantic, a leading global growth equity firm. This significant capital infusion marks a pivotal moment for the company, underscoring the growing recognition and potential of technology dedicated to women’s health.

Founded in 2015, Flo Health has swiftly risen to prominence with its innovative mobile application designed to track menstrual cycles, ovulation, and overall reproductive health. The app has garnered over 230 million downloads globally, making it a crucial tool for millions of women seeking to manage their health more effectively. This investment from General Atlantic is poised to propel Flo Health into its next phase of growth, enabling it to expand its product offerings and enhance its technological capabilities.

General Atlantic’s decision to invest such a substantial sum is indicative of the broader trends within the femtech sector. The femtech market, which includes a range of products and services aimed at improving women’s health, is projected to grow exponentially over the next decade. The increasing awareness of women’s health issues, coupled with advancements in technology, has created a fertile ground for innovation and investment. By backing Flo Health, General Atlantic is not only supporting a single company but also signalling confidence in the sector’s future.

Yaroslava Goncharova, CEO of Flo Health, expressed enthusiasm about the partnership with General Atlantic, stating, “This investment will allow us to accelerate our mission of improving the health and wellbeing of women globally. We are excited to leverage General Atlantic’s expertise and resources to further enhance our product and reach more women around the world.”

Flo Health’s success is rooted in its user-centric approach, leveraging data science and artificial intelligence to provide personalised health insights. The app’s features include symptom tracking, health predictions, and educational content, all designed to empower women with knowledge about their bodies. With the new funding, Flo Health plans to deepen its AI capabilities, enhance its user experience, and expand its educational content, ensuring it remains at the forefront of the femtech industry.

General Atlantic, known for its strategic investments in technology and healthcare, sees Flo Health as a strategic addition to its portfolio. Sandeep Naik, Managing Director and Head of India & Southeast Asia at General Atlantic, highlighted the potential for growth in the femtech space. “Flo Health is at the intersection of healthcare and technology, addressing a significant market need with its innovative solutions. We believe in the company’s vision and are committed to supporting its growth trajectory.”

The $200 million investment also reflects a broader shift in the investment landscape, where gender-specific health solutions are gaining traction among investors. The femtech sector, which has historically been underfunded, is now witnessing increased interest and funding, signalling a positive change in how women’s health is valued and supported.

Flo Health’s journey from a startup to a leading player in femtech exemplifies the transformative potential of technology in healthcare. With General Atlantic’s backing, the company is well-positioned to continue its upward trajectory, driving innovation and improving health outcomes for women worldwide. As Flo Health embarks on this new chapter, the femtech industry will undoubtedly be watching closely, anticipating the strides the company will make in advancing women’s health.

Women Make Up A Majority Of The EU’s Science And Technology Workforce But The Real Gap Is Elsewhere

Women now make up the majority of the EU’s science and technology workforce. According to Eurostat, in 2025, more than 81.6 million people aged 15 to 74 were employed in science and technology occupations across the EU. Of those, 52.5% were women, equal to 42.8 million women. The number of women in these occupations rose by 27.9% compared with 2015, an increase of more than 9.3 million over a decade.

On the surface, the numbers resemble progress. However, Eurostat’s category requires context before that figure can be read accurately. The data refers to HRST, or Human Resources in Science and Technology, specifically people employed in science and technology occupations. These are roles where the main tasks require professional or technical knowledge in physical and life sciences, but also in social sciences and humanities. That definition is wider and broader than engineering, ICT, laboratory science, or high-tech research alone.

Zooming In

The gender picture changes once the data moves from a wider definition of the workforce to the narrower scientist-and-engineer (research and manufacturing) subgroup.

Scientists and engineers represented almost a quarter of all people employed in science and technology in the EU in 2025. Eurostat describes scientists and engineers as often being the innovators at the centre of technology-led development, making them an important subgroup to focus on separately.

Women accounted for only 40.8% of scientists and engineers in 2025, despite making up more than half of the wider category. That share has increased by a mere 0.5 percentage points over the past decade. The absolute number of women working as scientists and engineers rose from 5.3 million in 2015 to 8.2 million in 2025, despite the push from national and international organisations to increase the number of women in the field. Europe has expanded the number of women in science and technology occupations over ten years. However, that expansion has not extended equally into the scientist-and-engineer subgroup, where much of Europe’s research and innovation work is conducted.

In 2025, of the 39.4 million women aged 25 to 64 working in science and technology occupations in the EU, 35.5 million worked in service activities. Only 2.7 million worked in manufacturing. Women accounted for 57.5% of science and technology employment in services, but only 31.3% in manufacturing.

In 2025, the highest shares of women employed in science and technology occupations were recorded in Latvia at 62.4%, followed by Hungary’s Great Plain and North region at 61.1%, Estonia at 60.5%, Poland’s Central macroregion at 60.4%, and Lithuania at 60.3%. No EU country recorded a majority of women among science and technology workers in manufacturing.

Break-down

Eurostat’s figures measure employment in broad science and technology occupations. They do not show job security, pay levels, management roles, promotion rates, research leadership, or whether women are concentrated in junior or senior workplace positions.

The classification of “senior” also requires additional explanation. Eurostat reports that 45.9% of science and technology workers aged 25 to 64 in the EU were classified as “senior” HRST in 2025. In this dataset, “senior” refers to workers aged 45 to 64. It does not mean senior manager, senior researcher, team lead, or decision-maker.

A high female share in the wider Human Resource Science and Technology (HRST) category does not parallel equal representation across scientists, engineers, manufacturing roles, senior posts, pay, research funding, or decision-making. These figures also reflect the occupational mix inside each country or region, not only structural progress across all areas of science and technology.

The Case Of Cyprus

Eurostat data places Cyprus’s overall science and technology employment at 37.2% of the labour force in 2025, slightly above the EU-27 figure of 36.9%, and above Greece at 26.8%, Malta at 33.9%, and Turkey at 18.2%. This figure covers the total share of the labour force employed in science and technology across all genders.

Progress Or Work-in-Progress?

52.5% in the broad category. 40.8% among scientists and engineers. 31.3% in manufacturing. Europe’s gender gap in science and technology hasn’t closed yet, and there is still work to be done to encourage and support more women to enter the field, especially in research and manufacturing.

Let’s not wait another decade for another couple of percentage points of hope.

Aretilaw firm
The Future Forbes Realty Global Properties
eCredo
Uol

Become a Speaker

Become a Speaker

Become a Partner

Subscribe for our weekly newsletter